Marshall Wace’s Core Laboratories CLB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,123
| Closed | -$193K | – | 2525 |
|
|
2024
Q4 | $193K | Sell |
11,123
-10,188
| -48% | -$176K | ﹤0.01% | 2204 |
|
|
2024
Q3 | $395K | Sell |
21,311
-59,741
| -74% | -$1.11M | ﹤0.01% | 1864 |
|
|
2024
Q2 | $1.64M | Sell |
81,052
-41,819
| -34% | -$849K | ﹤0.01% | 1324 |
|
|
2024
Q1 | $2.1M | Buy |
122,871
+104,510
| +569% | +$1.79M | ﹤0.01% | 1177 |
|
|
2023
Q4 | $324K | Buy |
+18,361
| New | +$324K | ﹤0.01% | 1564 |
|
|
2023
Q2 | – | Sell |
-19,970
| Closed | -$440K | – | 2070 |
|
|
2023
Q1 | $440K | Buy |
+19,970
| New | +$440K | ﹤0.01% | 1692 |
|
|
2022
Q4 | – | Sell |
-124,469
| Closed | -$1.68M | – | 2378 |
|
|
2022
Q3 | $1.68M | Buy |
124,469
+38,029
| +44% | +$512K | ﹤0.01% | 1622 |
|
|
2022
Q2 | $1.71M | Buy |
+86,440
| New | +$1.71M | ﹤0.01% | 1650 |
|
|
2022
Q1 | – | Sell |
-835,491
| Closed | -$18.6M | – | 2695 |
|
|
2021
Q4 | $18.6M | Buy |
835,491
+662,216
| +382% | +$14.8M | 0.03% | 473 |
|
|
2021
Q3 | $4.81M | Buy |
+173,275
| New | +$4.81M | 0.02% | 839 |
|
|
2019
Q2 | – | Sell |
-433
| Closed | -$30K | – | 1375 |
|
|
2019
Q1 | $30K | Buy |
+433
| New | +$30K | ﹤0.01% | 1582 |
|
|
2017
Q1 | – | Sell |
-8,065
| Closed | -$968K | – | 374 |
|
|
2016
Q4 | $968K | Sell |
8,065
-62,437
| -89% | -$7.49M | 0.01% | 756 |
|
|
2016
Q3 | $7.92M | Sell |
70,502
-136,875
| -66% | -$15.4M | 0.06% | 320 |
|
|
2016
Q2 | $25.7M | Buy |
207,377
+103,785
| +100% | +$12.9M | 0.22% | 114 |
|
|
2016
Q1 | $11.6M | Buy |
+103,592
| New | +$11.6M | 0.11% | 190 |
|